 |
28 Diseases |  |
0 Trials |
|
0 Trials |  |
2 News |  |
- CDX 1307 / Celldex
Enrollment change: A Study of the CDX-1307 Vaccine Regimen in Patients With Newly Diagnosed Muscle-Invasive Bladder Cancer (The "N-ABLE" Study) (clinicaltrials.gov) - Feb 13, 2020
P2, N=3, Terminated, Sponsor: Celldex Therapeutics
N=30 --> 3
- CDX 1307 / Celldex
Trial primary completion date: A Study of the CDX-1307 Vaccine Regimen in Patients With Newly Diagnosed Muscle-Invasive Bladder Cancer (The "N-ABLE" Study) (clinicaltrials.gov) - Aug 13, 2015
P2, N=30, Terminated, Sponsor: Celldex Therapeutics
N=30 --> 3 Trial primary completion date: Apr 2015 --> Jul 2011